- Tytuł:
- A phase IIb, randomised, double-blind, placebo-controlled, dose-ranging investigation of the safety and efficacy of NTCELL® [immunoprotected (alginate-encapsulated) porcine choroid plexus cells for xenotransplantation] in patients with Parkinson's disease
- Autorzy:
- Źródło:
- In Parkinsonism and Related Disorders April 2019 61:88-93
Czasopismo naukowe